BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24349050)

  • 21. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.
    Faivre L; Masurel-Paulet A; Collod-Béroud G; Callewaert BL; Child AH; Stheneur C; Binquet C; Gautier E; Chevallier B; Huet F; Loeys BL; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Halliday DJ; Béroud C; Bonithon-Kopp C; Claustres M; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Pediatrics; 2009 Jan; 123(1):391-8. PubMed ID: 19117906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An FBN1 pseudoexon mutation in a patient with Marfan syndrome: confirmation of cryptic mutations leading to disease.
    Guo DC; Gupta P; Tran-Fadulu V; Guidry TV; Leduc MS; Schaefer FV; Milewicz DM
    J Hum Genet; 2008; 53(11-12):1007-1011. PubMed ID: 18795226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two novel mutations in fibrillin-1 gene of Marfan syndrome].
    Huang X; Wu Y; Chen F; Huang Y; Ma X; Chen T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):562-5. PubMed ID: 15583982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.
    Cecchi A; Ogawa N; Martinez HR; Carlson A; Fan Y; Penny DJ; Guo DC; Eisenberg S; Safi H; Estrera A; Lewis RA; Meyers D; Milewicz DM
    Am J Med Genet A; 2013 Sep; 161A(9):2305-10. PubMed ID: 23897642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recurring FBN1 gene mutation in neonatal Marfan syndrome.
    Jacobs AM; Toudjarska I; Racine A; Tsipouras P; Kilpatrick MW; Shanske A
    Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1081-5. PubMed ID: 12413333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.
    Wang M; Kishnani P; Decker-Phillips M; Kahler SG; Chen YT; Godfrey M
    J Med Genet; 1996 Sep; 33(9):760-3. PubMed ID: 8880577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis.
    Attanasio M; Pratelli E; Porciani MC; Evangelisti L; Torricelli E; Pellicanò G; Abbate R; Gensini GF; Pepe G
    Eur J Med Genet; 2013 Jul; 56(7):356-60. PubMed ID: 23684891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
    Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
    J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology and fibrillin-1 distribution in severe early onset Marfan syndrome.
    Summers KM; Nataatmadja M; Xu D; West MJ; McGill JJ; Whight C; Colley A; Adès LC
    Am J Med Genet A; 2005 Nov; 139(1):2-8. PubMed ID: 16222666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families.
    Zhao F; Pan X; Zhao K; Zhao C
    Mol Vis; 2013; 19():751-8. PubMed ID: 23592911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.
    Attanasio M; Lapini I; Evangelisti L; Lucarini L; Giusti B; Porciani M; Fattori R; Anichini C; Abbate R; Gensini G; Pepe G
    Clin Genet; 2008 Jul; 74(1):39-46. PubMed ID: 18435798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
    Dietz HC; Pyeritz RE
    Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute mitral regurgitation due to chordal rupture in a patient with neonatal Marfan syndrome caused by a deletion in exon 29 of the FBN1 gene.
    Weidenbach M; Brenner R; Rantamäki T; Redel DA
    Pediatr Cardiol; 1999; 20(5):382-5. PubMed ID: 10441700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of premature ventricular contractions and non-sustained ventricular tachycardia in light-chain cardiac amyloidosis.
    Chen Z; Shi A; Dong H; Laptseva N; Chen F; Yang J; Guo X; Duru F; Chen K; Chen L
    Europace; 2024 Mar; 26(3):. PubMed ID: 38466042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome.
    Loeys B; De Backer J; Van Acker P; Wettinck K; Pals G; Nuytinck L; Coucke P; De Paepe A
    Hum Mutat; 2004 Aug; 24(2):140-6. PubMed ID: 15241795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular systolic dysfunction in asymptomatic Marfan syndrome patients is related to the severity of gene mutation: insights from the novel three dimensional speckle tracking echocardiography.
    Abd El Rahman M; Haase D; Rentzsch A; Olchvary J; Schäfers HJ; Henn W; Wagenpfeil S; Abdul-Khaliq H
    PLoS One; 2015; 10(4):e0124112. PubMed ID: 25901601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.
    Demolder A; Bianco L; Caruana M; Cervi E; Evangelista A; Jondeau G; Buttigieg LL; López-Sainz Á; Delmás EM; Pini A; Sabaté-Rotés A; Szöcs K; Tchitchinadze M; Teixidó-Tura G; von Kodolitsch Y; Muiño-Mosquera L; De Backer J
    Eur J Med Genet; 2022 Jun; 65(6):104503. PubMed ID: 35427808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular manifestations in men and women carrying a FBN1 mutation.
    Détaint D; Faivre L; Collod-Beroud G; Child AH; Loeys BL; Binquet C; Gautier E; Arbustini E; Mayer K; Arslan-Kirchner M; Stheneur C; Halliday D; Beroud C; Bonithon-Kopp C; Claustres M; Plauchu H; Robinson PN; Kiotsekoglou A; De Backer J; Adès L; Francke U; De Paepe A; Boileau C; Jondeau G
    Eur Heart J; 2010 Sep; 31(18):2223-9. PubMed ID: 20709720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification for serious arrhythmic events using nonsustained ventricular tachycardia and heart rate turbulence detected by 24-hour holter electrocardiograms in patients with left ventricular dysfunction.
    Miwa Y; Yoshino H; Hoshida K; Miyakoshi M; Tsukada T; Yusu S; Ikeda T
    Ann Noninvasive Electrocardiol; 2012 Jul; 17(3):260-7. PubMed ID: 22816545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients.
    Hayward C; Rae AL; Porteous ME; Logie LJ; Brock DJ
    Hum Mol Genet; 1994 Feb; 3(2):373-5. PubMed ID: 8004112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.